{
  "legislationId": "119_HR_7694",
  "lastUpdate": "2026-04-17T11:38:49.883Z",
  "history": [
    {
      "timestamp": "2026-04-17T11:38:49.883Z",
      "source_url": "https://www.congress.gov/119/bills/hr7694/BILLS-119hr7694ih.htm",
      "model": "gemini-3.1-pro-preview",
      "prompt_sent": "\nJesteś LEGISLATIVE SURGEON.\nTwoim zadaniem jest audyt i naprawa streszczenia (JSON) pod kątem zgodności z tekstem źródłowym (SOURCE).\nZASADA FUNDAMENTALNA: \"NO NEW INFORMATION\" (żadnych nowych informacji).\nStreszczenie może jedynie transformować informacje zawarte w SOURCE (skracać, tłumaczyć, sumować). Nie może generować nowych informacji, których nie ma w SOURCE.\n\nPROCEDURA WERYFIKACJI (wykonaj dla każdego zdania w JSON):\nZadaj sobie pytanie: \"Czy potrafię wskazać w SOURCE konkretny fragment, który potwierdza to stwierdzenie?\"\nJEŚLI ODPOWIEDŹ BRZMI \"TAK\":\nInformacja jest potwierdzona cytatem, synonimem lub wynikiem matematycznym z danych w tekście.\nDECYZJA: Zostaw bez zmian.\nJEŚLI ODPOWIEDŹ BRZMI \"NIE\":\nInformacji nie ma w tekście (jest to halucynacja, zewnętrzna wiedza modelu, nadinterpretacja lub niepotrzebna ekstrapolacja).\nDECYZJA: Usuń tę informację lub zmień ją tak, aby miała pokrycie w tekście.\nJEŚLI ODPOWIEDŹ BRZMI \"TO ZALEŻY\":\nTekst jest niejasny, a streszczenie \"zgaduje\" (np. podając konkretny przykład dla ogólnego terminu).\nDECYZJA: Bądź bezpieczny. Usuń zgadywanie. Użyj terminologii z tekstu.\n\nKATEGORIE RYZYKA (szczególna uwaga):\nDaty (start obowiązywania vs start finansowania).\nLiczby (konkretne kwoty muszą wynikać z tekstu).\nPodmioty (kto co robi).\nZakres (co ustawa obejmuje, a czego nie).\n\nINPUT:\n--- SOURCE_TEXT START ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7694 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7694 To direct the Secretary of Health and Human Services to carry out a public awareness campaign to increase participation by women in clinical trials that are conducted or supported by the National Institutes of Health, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES February 25, 2026 Mr. Gottheimer (for himself, Ms. Pettersen, and Mr. Lawler) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To direct the Secretary of Health and Human Services to carry out a public awareness campaign to increase participation by women in clinical trials that are conducted or supported by the National Institutes of Health, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Gwenn's Law''. SEC. 2. PUBLIC AWARENESS CAMPAIGN TO INCREASE PARTICIPATION OF WOMEN IN NIH CLINICAL TRIALS. (a) In General.--The Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (in this section referred to as the ``Secretary'') shall carry out a public awareness campaign to increase the participation of women in clinical trials conducted or supported by the National Institutes of Health. (b) Targeted Outreach.--In carrying out the campaign under subsection (a), the Secretary shall increase outreach at hospitals, physicians' offices, health centers, health care clinics, and other locations that the Secretary determines appropriate. (c) Priority.--In carrying out the campaign under subsection (a), the Secretary shall prioritize increasing the participation of women in clinical trials involving research on, and development of, products to prevent, diagnose, or treat rare diseases and conditions. (d) Authorization of Appropriations.--To carry out this section, there is authorized to be appropriated $10,000,000 for each of fiscal years 2027 through 2031. SEC. 3. PUBLIC AWARENESS CAMPAIGN TO INCREASE AWARENESS OF BLEEDING AND CLOTTING DISORDERS IN WOMEN. (a) In General.--The Secretary of Health and Human Services shall carry out a public awareness campaign to increase the number of women participating in programs of the Department of Health and Human Services for research, surveillance, and prevention with respect to bleeding and clotting disorders, including hemophilia. (b) Authorization of Appropriations.--To carry out this section, there is authorized to be appropriated $10,000,000 for each of fiscal years 2027 through 2031. SEC. 4. INTERAGENCY TASK FORCE ON ADVANCING TREATMENTS FOR RARE DISEASES. Part A of title III of the Public Health Service Act (42 U.S.C. 241 et seq.) is amended by adding at the end the following: ``SEC. 310C. INTERAGENCY TASK FORCE ON ADVANCING TREATMENTS FOR RARE DISEASES. ``(a) In General.--The Secretary shall maintain a permanent task force, to be known as the Interagency Task Force on Advancing Treatments for Rare Diseases (in this section referred to as the `Task Force'). The Secretary shall establish the Task Force not later than 90 days after the date of enactment of the legislation. ``(b) Composition.--The Task Force shall be composed of the following members: ``(1) The Secretary. ``(2) The Administrator of the Centers for Medicare & Medicaid Services. ``(3) The Commissioner of Food and Drugs. ``(4) The Director of the National Institutes of Health. ``(5) The Director of the Centers for Disease Control and Prevention. ``(6) Four individuals, to be appointed by the Secretary, who are-- ``(A) biopharmaceutical innovators with respect to rare diseases and conditions; ``(B) private health plan administrators; or ``(C) representatives of institutions or organizations conducting federally funded research with respect to rare diseases and conditions. ``(7) Four individuals, to be appointed by the Secretary, who are representatives of rare disease advocacy groups. ``(c) Duties.--The Task Force shall-- ``(1) assess-- ``(A) Federal agency activities concerning rare diseases, including projects involving two or more agencies; ``(B) overall programmatic funding; and ``(C) potential measurable outcomes to include in future reports; and ``(2) coordinate the efforts of the Department of Health and Human Services to incentivize research on, and development of, products for prevention, diagnosis, and treatment with respect to rare diseases and conditions, particularly rare diseases and conditions that disproportionately impact women.''. SEC. 5. ACTION PLAN FOR COORDINATING HHS EFFORTS WITH RESPECT TO CERTAIN RARE DISEASES AND CONDITIONS. (a) In General.--The Secretary of Health and Human Services shall prepare an action plan for coordinating efforts of the Department of Health and Human Services to incentivize research on, and development of, products for prevention, diagnosis, and treatment with respect to rare diseases and conditions that disproportionately impact women. (b) Submission and Public Availability.--Not later than 180 days after the date of enactment of this Act, the Secretary shall-- (1) complete the action plan required by subsection (a); (2) submit such action plan to the Congress; and (3) make such plan publicly available, including by posting on the websites of the Department of Health and Human Services and the National Institutes of Health. <all>\n--- SOURCE_TEXT END ---\n\n--- FLAGGED_JSON START ---\n{\n  \"pl_ai_title\": \"Ustawa Gwenn: Większy udział kobiet w badaniach medycznych i rzadkich chorobach\",\n  \"pl_summary\": \"Ustawa ma na celu zwiększenie udziału kobiet w badaniach klinicznych oraz podniesienie świadomości na temat chorób rzadkich i zaburzeń krzepnięcia krwi. Dzięki nowym kampaniom informacyjnym i funduszom, kobiety zyskają lepszy dostęp do nowoczesnych metod leczenia i diagnostyki.\",\n  \"pl_key_points\": [\n    \"Uruchomienie kampanii informacyjnych w szpitalach i przychodniach zachęcających kobiety do udziału w badaniach medycznych.\",\n    \"Przeznaczenie 20 milionów dolarów rocznie na edukację o badaniach klinicznych oraz zaburzeniach krzepnięcia krwi u kobiet.\",\n    \"Utworzenie stałego zespołu ekspertów do spraw przyspieszania prac nad lekami na choroby rzadkie.\",\n    \"Opracowanie publicznego planu działania dotyczącego chorób rzadkich, które najczęściej dotykają kobiety.\"\n  ],\n  \"eng_ai_title\": \"Gwenn’s Law: Increasing Women’s Participation in Medical Research and Rare Disease Awareness\",\n  \"eng_summary\": \"This bill aims to boost women's involvement in clinical trials and raise awareness about rare diseases and blood clotting disorders. Through new public campaigns and funding, women will have better access to information about cutting-edge medical research and treatments.\",\n  \"eng_key_points\": [\n    \"Launch of public awareness campaigns in hospitals and clinics to encourage women to join medical trials.\",\n    \"Allocation of $20 million annually for education on clinical trials and bleeding disorders in women.\",\n    \"Creation of a permanent Interagency Task Force to speed up the development of treatments for rare diseases.\",\n    \"Development of a public action plan focused on rare diseases that primarily affect women.\"\n  ],\n  \"de_ai_title\": \"Gwenn’s Law: Mehr Frauen in der medizinischen Forschung und Aufklärung über seltene Krankheiten\",\n  \"de_summary\": \"Dieses Gesetz zielt darauf ab, die Beteiligung von Frauen an klinischen Studien zu erhöhen und das Bewusstsein für seltene Krankheiten sowie Blutgerinnungsstörungen zu schärfen. Durch neue Informationskampagnen und Fördermittel erhalten Frauen besseren Zugang zu modernster medizinischer Forschung.\",\n  \"de_key_points\": [\n    \"Start von Aufklärungskampagnen in Krankenhäusern und Praxen, um Frauen zur Teilnahme an medizinischen Studien zu motivieren.\",\n    \"Bereitstellung von jährlich 20 Millionen Dollar für die Aufklärung über klinische Studien und Gerinnungsstörungen bei Frauen.\",\n    \"Gründung einer ständigen Expertengruppe zur Beschleunigung der Entwicklung von Medikamenten gegen seltene Krankheiten.\",\n    \"Erstellung eines öffentlichen Aktionsplans für seltene Krankheiten, die überproportional häufig Frauen betreffen.\"\n  ],\n  \"fr_ai_title\": \"Loi Gwenn : Accroître la participation des femmes à la recherche médicale et aux maladies rares\",\n  \"fr_summary\": \"Ce projet de loi vise à accroître la participation des femmes aux essais cliniques et à sensibiliser le public aux maladies rares et aux troubles de la coagulation. Grâce à de nouvelles campagnes d'information, les femmes auront un meilleur accès aux avancées médicales.\",\n  \"fr_key_points\": [\n    \"Lancement de campagnes de sensibilisation dans les hôpitaux pour encourager les femmes à participer aux essais médicaux.\",\n    \"Allocation de 20 millions de dollars par an pour l'éducation sur les essais cliniques et les troubles hémorragiques chez les femmes.\",\n    \"Création d'un groupe de travail permanent pour accélérer le développement de traitements contre les maladies rares.\",\n    \"Élaboration d'un plan d'action public axé sur les maladies rares qui touchent principalement les femmes.\"\n  ],\n  \"es_ai_title\": \"Ley Gwenn: Aumento de la participación de las mujeres en la investigación médica y enfermedades raras\",\n  \"es_summary\": \"Esta ley busca aumentar la participación de las mujeres en ensayos clínicos y mejorar la concienciación sobre enfermedades raras y trastornos de la coagulación. Mediante nuevas campañas y fondos, las mujeres tendrán mejor acceso a información sobre tratamientos innovadores.\",\n  \"es_key_points\": [\n    \"Lanzamiento de campañas de concienciación en hospitales y clínicas para animar a las mujeres a participar en estudios médicos.\",\n    \"Asignación de 20 millones de dólares anuales para educación sobre ensayos clínicos y trastornos de la coagulación en mujeres.\",\n    \"Creación de un grupo de trabajo permanente para acelerar el desarrollo de tratamientos para enfermedades raras.\",\n    \"Desarrollo de un plan de acción público sobre enfermedades raras que afectan desproporcionadamente a las mujeres.\"\n  ],\n  \"it_ai_title\": \"Legge Gwenn: Aumentare la partecipazione delle donne alla ricerca medica e alle malattie rare\",\n  \"it_summary\": \"Questa legge mira a potenziare il coinvolgimento delle donne negli studi clinici e a sensibilizzare l'opinione pubblica sulle malattie rare e i disturbi della coagulazione. Grazie a nuove campagne informative, le donne avranno un accesso facilitato alle scoperte mediche.\",\n  \"it_key_points\": [\n    \"Avvio di campagne di sensibilizzazione in ospedali e cliniche per incoraggiare le donne a partecipare ai test medici.\",\n    \"Stanziamento di 20 milioni di dollari all'anno per l'educazione sui test clinici e i disturbi emorragici femminili.\",\n    \"Istituzione di una task force permanente per accelerare lo sviluppo di cure per le malattie rare.\",\n    \"Creazione di un piano d'azione pubblico per le malattie rare che colpiscono prevalentemente le donne.\"\n  ],\n  \"nl_ai_title\": \"Gwenn’s Law: Verhoging van de deelname van vrouwen aan medisch onderzoek en zeldzame ziekten\",\n  \"nl_summary\": \"Dit wetsvoorstel is bedoeld om de betrokkenheid van vrouwen bij klinische proeven te vergroten en het bewustzijn over zeldzame ziekten en bloedstollingsstoornissen te verhogen. Door nieuwe campagnes krijgen vrouwen betere toegang tot informatie over medische innovaties.\",\n  \"nl_key_points\": [\n    \"Lancering van voorlichtingscampagnes in ziekenhuizen om vrouwen aan te moedigen deel te nemen aan medisch onderzoek.\",\n    \"Toewijzing van 20 miljoen dollar per jaar voor educatie over klinische proeven en stollingsstoornissen bij vrouwen.\",\n    \"Oprichting van een permanente werkgroep om de ontwikkeling van behandelingen voor zeldzame ziekten te versnellen.\",\n    \"Opstelling van een openbaar actieplan voor zeldzame ziekten die vrouwen onevenredig vaak treffen.\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Lançamento de campanhas de sensibilização em hospitais para incentivar as mulheres a participar em ensaios médicos.\",\n    \"Alocação de 20 milhões de dólares anuais para educação sobre ensaios clínicos e distúrbios hemorrágicos em mulheres.\",\n    \"Criação de uma força-tarefa permanente para acelerar o desenvolvimento de tratamentos para doenças raras.\",\n    \"Desenvolvimento de um plano de ação público focado em doenças raras que afetam desproporcionalmente as mulheres.\"\n  ],\n  \"category\": [\n    \"Health\"\n  ]\n}\n--- FLAGGED_JSON END ---\n\nOUTPUT:\nWyłącznie naprawiony obiekt JSON zgodny ze strukturą:\n{\n  \"pl_ai_title\": \"...\", \"pl_summary\": \"...\", \"pl_key_points\": [...],\n  \"eng_ai_title\": \"...\", \"eng_summary\": \"...\", \"eng_key_points\": [...],\n  \"de_ai_title\": \"...\", \"de_summary\": \"...\", \"de_key_points\": [...],\n  \"fr_ai_title\": \"...\", \"fr_summary\": \"...\", \"fr_key_points\": [...],\n  \"es_ai_title\": \"...\", \"es_summary\": \"...\", \"es_key_points\": [...],\n  \"it_ai_title\": \"...\", \"it_summary\": \"...\", \"it_key_points\": [...],\n  \"nl_ai_title\": \"...\", \"nl_summary\": \"...\", \"nl_key_points\": [...],\n  \"pt_ai_title\": \"...\", \"pt_summary\": \"...\", \"pt_key_points\": [...],\n  \"category\": [\"...\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Ustawa Gwenn: Większy udział kobiet w badaniach klinicznych i świadomość chorób rzadkich\",\n  \"pl_summary\": \"Ustawa ma na celu zwiększenie udziału kobiet w badaniach klinicznych oraz podniesienie świadomości na temat chorób rzadkich i zaburzeń krzepnięcia krwi. Wprowadza kampanie informacyjne, powołuje grupę roboczą ds. chorób rzadkich oraz wymaga opracowania planu działania w tym zakresie.\",\n  \"pl_key_points\": [\n    \"Uruchomienie kampanii informacyjnych w szpitalach i przychodniach zachęcających kobiety do udziału w badaniach klinicznych.\",\n    \"Przeznaczenie 20 milionów dolarów rocznie (w latach 2027-2031) na kampanie dotyczące badań klinicznych oraz zaburzeń krzepnięcia krwi u kobiet.\",\n    \"Utworzenie stałego zespołu ekspertów do spraw przyspieszania prac nad lekami na choroby rzadkie.\",\n    \"Opracowanie publicznego planu działania dotyczącego chorób rzadkich, które nieproporcjonalnie dotykają kobiety.\"\n  ],\n  \"eng_ai_title\": \"Gwenn’s Law: Increasing Women’s Participation in Clinical Trials and Rare Disease Awareness\",\n  \"eng_summary\": \"This bill aims to boost women's involvement in clinical trials and raise awareness about rare diseases and blood clotting disorders. It introduces public awareness campaigns, establishes a task force for rare diseases, and requires the development of an action plan.\",\n  \"eng_key_points\": [\n    \"Launch of public awareness campaigns in hospitals and clinics to encourage women to join clinical trials.\",\n    \"Allocation of $20 million annually (fiscal years 2027-2031) for campaigns on clinical trials and bleeding disorders in women.\",\n    \"Creation of a permanent Interagency Task Force to advance treatments for rare diseases.\",\n    \"Development of a public action plan focused on rare diseases that disproportionately impact women.\"\n  ],\n  \"de_ai_title\": \"Gwenn’s Law: Mehr Frauen in klinischen Studien und Aufklärung über seltene Krankheiten\",\n  \"de_summary\": \"Dieses Gesetz zielt darauf ab, die Beteiligung von Frauen an klinischen Studien zu erhöhen und das Bewusstsein für seltene Krankheiten sowie Blutgerinnungsstörungen zu schärfen. Es führt Informationskampagnen ein, gründet eine Arbeitsgruppe für seltene Krankheiten und fordert einen Aktionsplan.\",\n  \"de_key_points\": [\n    \"Start von Aufklärungskampagnen in Krankenhäusern und Praxen, um Frauen zur Teilnahme an klinischen Studien zu motivieren.\",\n    \"Bereitstellung von jährlich 20 Millionen Dollar (Haushaltsjahre 2027-2031) für Kampagnen zu klinischen Studien und Gerinnungsstörungen bei Frauen.\",\n    \"Gründung einer ständigen behördenübergreifenden Arbeitsgruppe zur Förderung von Behandlungen für seltene Krankheiten.\",\n    \"Erstellung eines öffentlichen Aktionsplans für seltene Krankheiten, die überproportional häufig Frauen betreffen.\"\n  ],\n  \"fr_ai_title\": \"Loi Gwenn : Accroître la participation des femmes aux essais cliniques et la sensibilisation aux maladies rares\",\n  \"fr_summary\": \"Ce projet de loi vise à accroître la participation des femmes aux essais cliniques et à sensibiliser le public aux maladies rares et aux troubles de la coagulation. Il introduit des campagnes d'information, crée un groupe de travail sur les maladies rares et exige l'élaboration d'un plan d'action.\",\n  \"fr_key_points\": [\n    \"Lancement de campagnes de sensibilisation dans les hôpitaux et cliniques pour encourager les femmes à participer aux essais cliniques.\",\n    \"Allocation de 20 millions de dollars par an (exercices 2027-2031) pour des campagnes sur les essais cliniques et les troubles hémorragiques chez les femmes.\",\n    \"Création d'un groupe de travail interorganisations permanent pour faire progresser les traitements contre les maladies rares.\",\n    \"Élaboration d'un plan d'action public axé sur les maladies rares qui touchent de manière disproportionnée les femmes.\"\n  ],\n  \"es_ai_title\": \"Ley Gwenn: Aumento de la participación de las mujeres en ensayos clínicos y concienciación sobre enfermedades raras\",\n  \"es_summary\": \"Esta ley busca aumentar la participación de las mujeres en ensayos clínicos y mejorar la concienciación sobre enfermedades raras y trastornos de la coagulación. Introduce campañas de concienciación, establece un grupo de trabajo para enfermedades raras y requiere el desarrollo de un plan de acción.\",\n  \"es_key_points\": [\n    \"Lanzamiento de campañas de concienciación en hospitales y clínicas para animar a las mujeres a participar en ensayos clínicos.\",\n    \"Asignación de 20 millones de dólares anuales (años fiscales 2027-2031) para campañas sobre ensayos clínicos y trastornos de la coagulación en mujeres.\",\n    \"Creación de un grupo de trabajo interinstitucional permanente para avanzar en los tratamientos de enfermedades raras.\",\n    \"Desarrollo de un plan de acción público sobre enfermedades raras que afectan desproporcionadamente a las mujeres.\"\n  ],\n  \"it_ai_title\": \"Legge Gwenn: Aumentare la partecipazione delle donne agli studi clinici e la consapevolezza sulle malattie rare\",\n  \"it_summary\": \"Questa legge mira a potenziare il coinvolgimento delle donne negli studi clinici e a sensibilizzare l'opinione pubblica sulle malattie rare e i disturbi della coagulazione. Introduce campagne informative, istituisce una task force per le malattie rare e richiede lo sviluppo di un piano d'azione.\",\n  \"it_key_points\": [\n    \"Avvio di campagne di sensibilizzazione in ospedali e cliniche per incoraggiare le donne a partecipare agli studi clinici.\",\n    \"Stanziamento di 20 milioni di dollari all'anno (anni fiscali 2027-2031) per campagne sugli studi clinici e i disturbi emorragici femminili.\",\n    \"Istituzione di una task force interagenzia permanente per promuovere i trattamenti per le malattie rare.\",\n    \"Creazione di un piano d'azione pubblico per le malattie rare che colpiscono in modo sproporzionato le donne.\"\n  ],\n  \"nl_ai_title\": \"Gwenn’s Law: Verhoging van de deelname van vrouwen aan klinische proeven en bewustzijn over zeldzame ziekten\",\n  \"nl_summary\": \"Dit wetsvoorstel is bedoeld om de betrokkenheid van vrouwen bij klinische proeven te vergroten en het bewustzijn over zeldzame ziekten en bloedstollingsstoornissen te verhogen. Het introduceert voorlichtingscampagnes, richt een taskforce op voor zeldzame ziekten en vereist de ontwikkeling van een actieplan.\",\n  \"nl_key_points\": [\n    \"Lancering van voorlichtingscampagnes in ziekenhuizen en klinieken om vrouwen aan te moedigen deel te nemen aan klinische proeven.\",\n    \"Toewijzing van 20 miljoen dollar per jaar (boekjaren 2027-2031) voor campagnes over klinische proeven en stollingsstoornissen bij vrouwen.\",\n    \"Oprichting van een permanente interdepartementale werkgroep om de ontwikkeling van behandelingen voor zeldzame ziekten te bevorderen.\",\n    \"Opstelling van een openbaar actieplan voor zeldzame ziekten die vrouwen onevenredig vaak treffen.\"\n  ],\n  \"pt_ai_title\": \"Lei Gwenn: Aumentar a Participação das Mulheres em Ensaios Clínicos e a Consciencialização sobre Doenças Raras\",\n  \"pt_summary\": \"Este projeto de lei visa aumentar o envolvimento das mulheres em ensaios clínicos e aumentar a consciencialização sobre doenças raras e distúrbios de coagulação sanguínea. Introduz campanhas de sensibilização, estabelece um grupo de trabalho para doenças raras e exige o desenvolvimento de um plano de ação.\",\n  \"pt_key_points\": [\n    \"Lançamento de campanhas de sensibilização em hospitais e clínicas para incentivar as mulheres a participar em ensaios clínicos.\",\n    \"Alocação de 20 milhões de dólares anuais (anos fiscais 2027-2031) para campanhas sobre ensaios clínicos e distúrbios hemorrágicos em mulheres.\",\n    \"Criação de uma força-tarefa interagências permanente para avançar nos tratamentos para doenças raras.\",\n    \"Desenvolvimento de um plano de ação público focado em doenças raras que afetam desproporcionalmente as mulheres.\"\n  ],\n  \"category\": [\n    \"Health\"\n  ]\n}"
    },
    {
      "timestamp": "2026-04-17T11:35:49.708Z",
      "source_url": "https://www.congress.gov/119/bills/hr7694/BILLS-119hr7694ih.htm",
      "model": "gemini-flash-lite-latest",
      "prompt_sent": "\nROLE: Fact Checker.\nZADANIE: Porównaj SOURCE (oryginał) i SUMMARY (streszczenie przygotowane przez inne AI).\n\nTwoim celem jest wykrycie \"ZMYŚLONYCH KONKRETÓW\" (Fabricated Entities) w SUMMARY.\n\nSOURCE:\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7694 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7694 To direct the Secretary of Health and Human Services to carry out a public awareness campaign to increase participation by women in clinical trials that are conducted or supported by the National Institutes of Health, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES February 25, 2026 Mr. Gottheimer (for himself, Ms. Pettersen, and Mr. Lawler) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To direct the Secretary of Health and Human Services to carry out a public awareness campaign to increase participation by women in clinical trials that are conducted or supported by the National Institutes of Health, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Gwenn's Law''. SEC. 2. PUBLIC AWARENESS CAMPAIGN TO INCREASE PARTICIPATION OF WOMEN IN NIH CLINICAL TRIALS. (a) In General.--The Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (in this section referred to as the ``Secretary'') shall carry out a public awareness campaign to increase the participation of women in clinical trials conducted or supported by the National Institutes of Health. (b) Targeted Outreach.--In carrying out the campaign under subsection (a), the Secretary shall increase outreach at hospitals, physicians' offices, health centers, health care clinics, and other locations that the Secretary determines appropriate. (c) Priority.--In carrying out the campaign under subsection (a), the Secretary shall prioritize increasing the participation of women in clinical trials involving research on, and development of, products to prevent, diagnose, or treat rare diseases and conditions. (d) Authorization of Appropriations.--To carry out this section, there is authorized to be appropriated $10,000,000 for each of fiscal years 2027 through 2031. SEC. 3. PUBLIC AWARENESS CAMPAIGN TO INCREASE AWARENESS OF BLEEDING AND CLOTTING DISORDERS IN WOMEN. (a) In General.--The Secretary of Health and Human Services shall carry out a public awareness campaign to increase the number of women participating in programs of the Department of Health and Human Services for research, surveillance, and prevention with respect to bleeding and clotting disorders, including hemophilia. (b) Authorization of Appropriations.--To carry out this section, there is authorized to be appropriated $10,000,000 for each of fiscal years 2027 through 2031. SEC. 4. INTERAGENCY TASK FORCE ON ADVANCING TREATMENTS FOR RARE DISEASES. Part A of title III of the Public Health Service Act (42 U.S.C. 241 et seq.) is amended by adding at the end the following: ``SEC. 310C. INTERAGENCY TASK FORCE ON ADVANCING TREATMENTS FOR RARE DISEASES. ``(a) In General.--The Secretary shall maintain a permanent task force, to be known as the Interagency Task Force on Advancing Treatments for Rare Diseases (in this section referred to as the `Task Force'). The Secretary shall establish the Task Force not later than 90 days after the date of enactment of the legislation. ``(b) Composition.--The Task Force shall be composed of the following members: ``(1) The Secretary. ``(2) The Administrator of the Centers for Medicare & Medicaid Services. ``(3) The Commissioner of Food and Drugs. ``(4) The Director of the National Institutes of Health. ``(5) The Director of the Centers for Disease Control and Prevention. ``(6) Four individuals, to be appointed by the Secretary, who are-- ``(A) biopharmaceutical innovators with respect to rare diseases and conditions; ``(B) private health plan administrators; or ``(C) representatives of institutions or organizations conducting federally funded research with respect to rare diseases and conditions. ``(7) Four individuals, to be appointed by the Secretary, who are representatives of rare disease advocacy groups. ``(c) Duties.--The Task Force shall-- ``(1) assess-- ``(A) Federal agency activities concerning rare diseases, including projects involving two or more agencies; ``(B) overall programmatic funding; and ``(C) potential measurable outcomes to include in future reports; and ``(2) coordinate the efforts of the Department of Health and Human Services to incentivize research on, and development of, products for prevention, diagnosis, and treatment with respect to rare diseases and conditions, particularly rare diseases and conditions that disproportionately impact women.''. SEC. 5. ACTION PLAN FOR COORDINATING HHS EFFORTS WITH RESPECT TO CERTAIN RARE DISEASES AND CONDITIONS. (a) In General.--The Secretary of Health and Human Services shall prepare an action plan for coordinating efforts of the Department of Health and Human Services to incentivize research on, and development of, products for prevention, diagnosis, and treatment with respect to rare diseases and conditions that disproportionately impact women. (b) Submission and Public Availability.--Not later than 180 days after the date of enactment of this Act, the Secretary shall-- (1) complete the action plan required by subsection (a); (2) submit such action plan to the Congress; and (3) make such plan publicly available, including by posting on the websites of the Department of Health and Human Services and the National Institutes of Health. <all>\n\nSUMMARY TO EVALUATE:\nTitle: Gwenn’s Law: Increasing Women’s Participation in Medical Research and Rare Disease Awareness\nSummary: This bill aims to boost women's involvement in clinical trials and raise awareness about rare diseases and blood clotting disorders. Through new public campaigns and funding, women will have better access to information about cutting-edge medical research and treatments.\nKey Points: Launch of public awareness campaigns in hospitals and clinics to encourage women to join medical trials., Allocation of $20 million annually for education on clinical trials and bleeding disorders in women., Creation of a permanent Interagency Task Force to speed up the development of treatments for rare diseases., Development of a public action plan focused on rare diseases that primarily affect women.\n\nZASADY OCENY:\n1. Sprawdź wszystkie LICZBY, DATY i KWOTY w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n2. Sprawdź wszystkie NAZWISKA, ORGANIZACJE i MIEJSCA w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n3. Sprawdź wszystkie konkretne DZIAŁANIA PRAWNE . Jeśli tego mechanizmu nie ma w SOURCE -> is_valid: false.\n\nWAŻNE: Abstrakcyjne pojęcia (np. \"transparentność\", \"zaufanie\") są dozwolone jako wnioski.\n\nOUTPUT (JSON):\n{\n  \"is_valid\": true/false,\n  \"issue\": \"fabricated_entity\" / \"contradiction\" / \"none\"\n}\n\nWYMAGANIA FORMATOWANIA:\n1. Odpowiedz WYŁĄCZNIE surowym obiektem JSON.\n2. NIE używaj bloków kodu Markdown.\n3. NIE dodawaj żadnych wstępów ani wyjaśnień przed ani po JSONie.\n4. JSON musi być poprawny i gotowy do parsowania.\n\n",
      "ai_response_raw": "{\n  \"is_valid\": false,\n  \"issue\": \"fabricated_entity\"\n}"
    },
    {
      "timestamp": "2026-04-17T11:32:58.176Z",
      "source_url": "https://www.congress.gov/119/bills/hr7694/BILLS-119hr7694ih.htm",
      "model": "gemini-flash-latest",
      "prompt_sent": "\nJesteś ekspertem od prawa Stanów Zjednoczonych, który ma za zadanie analizować dokumenty ustaw, uchwał oraz innych dokumentów legislacyjnych, a następnie przygotowywać z nich informacje w przystępny sposób dla obywateli. Twoim celem jest przedstawienie informacji tak, aby obywatele mogli sami ocenić wpływ legislacji na ich życie, nawet bez posiadania specjalistycznej wiedzy legislacyjnej. Skup się na faktach i obiektywnych skutkach wprowadzanych zmian, unikając wartościowania i osobistych opinii. Wszelki żargon prawny jest zabroniony. Prezentuj informacje w jasny, zwięzły i angażujący sposób, tak aby były zrozumiałe dla osoby bez wykształcenia prawniczego. Unikaj długich, złożonych zdań. Zamiast pisać \"projekt ma na celu nowelizację kodeksu podatkowego...\", napisz \"Zmiany w podatkach: nowe ulgi i obowiązki dla...\". Kontynuuj swoją pracę, dopóki nie rozwiążesz swojego zadania. Jeśli nie masz pewności co do generowanej treści, przeanalizuj dokument ponownie – nie zgaduj. Rozplanuj dobrze swoje zadanie przed przystąpieniem do niego. W podsumowaniu i kluczowych punktach, jeśli to możliwe i uzasadnione, podkreśl, jakie konkretne korzyści lub skutki (pozytywne lub negatywne) wprowadza ustawa dla życia codziennego obywateli, ich praw i obowiązków, finansów osobistych, bezpieczeństwa i innych ważnych kwestii (np. kategorycznych zakazów i nakazów czy najważniejszych konkretnych alokacji finansowych i terytorialnych).\n\nTwoja odpowiedź MUSI być w formacie JSON - i zawierać następujące klucze.\nZanim zwrócisz odpowiedź, dokładnie zweryfikuj, czy cała struktura JSON jest w 100% poprawna, włącznie ze wszystkimi przecinkami, nawiasami klamrowymi, kwadratowymi oraz cudzysłowami. Błędny JSON jest nieakceptowalny i uniemożliwi przetworzenie Twojej pracy.\n\nPrzeanalizuj dokładnie poniższy tekst dokumentu prawnego. To jest treść, na podstawie której masz wygenerować podsumowanie i kluczowe punkty:\n--- POCZĄTEK DOKUMENTU ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7694 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7694 To direct the Secretary of Health and Human Services to carry out a public awareness campaign to increase participation by women in clinical trials that are conducted or supported by the National Institutes of Health, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES February 25, 2026 Mr. Gottheimer (for himself, Ms. Pettersen, and Mr. Lawler) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To direct the Secretary of Health and Human Services to carry out a public awareness campaign to increase participation by women in clinical trials that are conducted or supported by the National Institutes of Health, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Gwenn's Law''. SEC. 2. PUBLIC AWARENESS CAMPAIGN TO INCREASE PARTICIPATION OF WOMEN IN NIH CLINICAL TRIALS. (a) In General.--The Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (in this section referred to as the ``Secretary'') shall carry out a public awareness campaign to increase the participation of women in clinical trials conducted or supported by the National Institutes of Health. (b) Targeted Outreach.--In carrying out the campaign under subsection (a), the Secretary shall increase outreach at hospitals, physicians' offices, health centers, health care clinics, and other locations that the Secretary determines appropriate. (c) Priority.--In carrying out the campaign under subsection (a), the Secretary shall prioritize increasing the participation of women in clinical trials involving research on, and development of, products to prevent, diagnose, or treat rare diseases and conditions. (d) Authorization of Appropriations.--To carry out this section, there is authorized to be appropriated $10,000,000 for each of fiscal years 2027 through 2031. SEC. 3. PUBLIC AWARENESS CAMPAIGN TO INCREASE AWARENESS OF BLEEDING AND CLOTTING DISORDERS IN WOMEN. (a) In General.--The Secretary of Health and Human Services shall carry out a public awareness campaign to increase the number of women participating in programs of the Department of Health and Human Services for research, surveillance, and prevention with respect to bleeding and clotting disorders, including hemophilia. (b) Authorization of Appropriations.--To carry out this section, there is authorized to be appropriated $10,000,000 for each of fiscal years 2027 through 2031. SEC. 4. INTERAGENCY TASK FORCE ON ADVANCING TREATMENTS FOR RARE DISEASES. Part A of title III of the Public Health Service Act (42 U.S.C. 241 et seq.) is amended by adding at the end the following: ``SEC. 310C. INTERAGENCY TASK FORCE ON ADVANCING TREATMENTS FOR RARE DISEASES. ``(a) In General.--The Secretary shall maintain a permanent task force, to be known as the Interagency Task Force on Advancing Treatments for Rare Diseases (in this section referred to as the `Task Force'). The Secretary shall establish the Task Force not later than 90 days after the date of enactment of the legislation. ``(b) Composition.--The Task Force shall be composed of the following members: ``(1) The Secretary. ``(2) The Administrator of the Centers for Medicare & Medicaid Services. ``(3) The Commissioner of Food and Drugs. ``(4) The Director of the National Institutes of Health. ``(5) The Director of the Centers for Disease Control and Prevention. ``(6) Four individuals, to be appointed by the Secretary, who are-- ``(A) biopharmaceutical innovators with respect to rare diseases and conditions; ``(B) private health plan administrators; or ``(C) representatives of institutions or organizations conducting federally funded research with respect to rare diseases and conditions. ``(7) Four individuals, to be appointed by the Secretary, who are representatives of rare disease advocacy groups. ``(c) Duties.--The Task Force shall-- ``(1) assess-- ``(A) Federal agency activities concerning rare diseases, including projects involving two or more agencies; ``(B) overall programmatic funding; and ``(C) potential measurable outcomes to include in future reports; and ``(2) coordinate the efforts of the Department of Health and Human Services to incentivize research on, and development of, products for prevention, diagnosis, and treatment with respect to rare diseases and conditions, particularly rare diseases and conditions that disproportionately impact women.''. SEC. 5. ACTION PLAN FOR COORDINATING HHS EFFORTS WITH RESPECT TO CERTAIN RARE DISEASES AND CONDITIONS. (a) In General.--The Secretary of Health and Human Services shall prepare an action plan for coordinating efforts of the Department of Health and Human Services to incentivize research on, and development of, products for prevention, diagnosis, and treatment with respect to rare diseases and conditions that disproportionately impact women. (b) Submission and Public Availability.--Not later than 180 days after the date of enactment of this Act, the Secretary shall-- (1) complete the action plan required by subsection (a); (2) submit such action plan to the Congress; and (3) make such plan publicly available, including by posting on the websites of the Department of Health and Human Services and the National Institutes of Health. <all>\n--- KONIEC DOKUMENTU ---\n\nPAMIĘTAJ: Twoja odpowiedź MUSI być wyłącznie poprawnym obiektem JSON. Nie dodawaj żadnych dodatkowych znaków, komentarzy ani tekstu przed znacznikiem '{' ani po znaczniku '}'. Cała odpowiedź musi być parsowalna jako JSON.\nNa podstawie POWYŻSZEGO dokumentu, wypełnij poniższą strukturę JSON:\nOto struktura JSON, której oczekuję (wypełnij ją treścią):\n{\n  \"pl_ai_title\": \"Nowy, krótki tytuł dla aktu prawnego po polsku, oddający sedno wprowadzanych zmian (np. maksymalnie 10-12 słów).\",\n  \"pl_summary\": \"2-3 zdania zwięzłego podsumowania treści aktu prawnego po polsku, napisane z perspektywy wpływu na życie codzienne obywateli.\",\n  \"pl_key_points\": [\n    \"Pierwszy krótki punkt po polsku dotyczący najważniejszych wprowadzanych rozwiązań lub zmian.\",\n    \"Drugi krótki punkt po polsku...\"\n  ],\n  \"eng_ai_title\": \"A new, short title for the legal act in English, capturing the essence of the changes (e.g., max 10-12 words).\",\n  \"eng_summary\": \"2-3 sentences summarizing the legal act in English, from the perspective of its impact on citizens' daily lives.\",\n  \"eng_key_points\": [\n    \"First short bullet point in English regarding the most important solutions or changes being introduced.\",\n    \"Second short bullet point in English...\"\n  ],\n  \"de_ai_title\": \"Ein neuer, kurzer Titel für das Rechtsdokument auf Deutsch, der den Kern der Änderungen erfasst (z.B. max. 10-12 Wörter).\",\n  \"de_summary\": \"2-3 Sätze Zusammenfassung des Rechtsdokuments auf Deutsch, aus der Perspektive seiner Auswirkungen auf das tägliche Leben der Bürger.\",\n  \"de_key_points\": [\n    \"Erster kurzer Stichpunkt auf Deutsch zu den wichtigsten eingeführten Lösungen oder Änderungen.\",\n    \"Zweiter kurzer Stichpunkt auf Deutsch...\"\n  ],\n  \"fr_ai_title\": \"Un nouveau titre court pour l'acte juridique en français, saisissant l'essence des changements (par exemple, 10-12 mots maximum).\",\n  \"fr_summary\": \"Résumé de 2-3 phrases de l'acte juridique en français, du point de vue de son impact sur la vie quotidienne des citoyens.\",\n  \"fr_key_points\": [\n    \"Premier court point en français concernant les solutions ou changements les plus importants introduits.\",\n    \"Deuxième court point en français...\"\n  ],\n  \"es_ai_title\": \"Un nuevo título breve para el acto jurídico en español, que recoja la esencia de los cambios (por ejemplo, máximo 10-12 palabras).\",\n  \"es_summary\": \"Resumen de 2-3 frases del acto jurídico en español, desde la perspectiva de su impacto en la vida cotidiana de los ciudadanos.\",\n  \"es_key_points\": [\n    \"Primer punto breve en español sobre las soluciones o cambios más importantes que se introducen.\",\n    \"Segundo punto breve en español...\"\n  ],\n  \"it_ai_title\": \"Un nuovo titolo breve per l'atto giuridico in italiano, che colga l'essenza delle modifiche (ad es. massimo 10-12 parole).\",\n  \"it_summary\": \"Riepilogo di 2-3 frasi dell'atto giuridico in italiano, dal punto di vista del suo impatto sulla vita quotidiana dei cittadini.\",\n  \"it_key_points\": [\n    \"Primo breve punto in italiano riguardante le soluzioni o le modifiche più importanti introdotte.\",\n    \"Secondo breve punto in italiano...\"\n  ],\n  \"nl_ai_title\": \"Een nieuwe, korte titel voor de rechtshandeling in het Nederlands, die de essentie van de wijzigingen weergeeft (bijv. max. 10-12 woorden).\",\n  \"nl_summary\": \"Samenvatting van 2-3 zinnen van de rechtshandeling in het Nederlands, vanuit het perspectief van de impact op het dagelijks leven van burgers.\",\n  \"nl_key_points\": [\n    \"Eerste korte punt in het Nederlands betreffende de belangrijkste geïntroduceerde oplossingen of wijzigingen.\",\n    \"Tweede korte punt in het Nederlands...\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Primeiro ponto curto em português sobre as soluções ou alterações mais importantes introduzidas.\",\n    \"Segundo ponto curto em português...\"\n  ],\n  \"category\": [\"Categorize the document into one category by default, based on the field it primarily concerns. Choose up to 3 if the document also touches upon SIGNIFICANT issues from other categories. You MUST select categories ONLY from the following list: Health, Education, Family, Taxes, Labor, Security, Environment, Courts and Law, Transport, Benefits, Real Estate, Media and Culture, Local Government, Migration, Agriculture, Public Investments, Informatization, Economy. If the document does not definitively fit any of these, you MUST use \"Other\". If you use \"Other\", it should be the ONLY category selected. Do NOT invent new categories. The response must be an array of strings, e.g., [\"Taxes\", \"Family\"].\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Ustawa Gwenn: Większy udział kobiet w badaniach medycznych i rzadkich chorobach\",\n  \"pl_summary\": \"Ustawa ma na celu zwiększenie udziału kobiet w badaniach klinicznych oraz podniesienie świadomości na temat chorób rzadkich i zaburzeń krzepnięcia krwi. Dzięki nowym kampaniom informacyjnym i funduszom, kobiety zyskają lepszy dostęp do nowoczesnych metod leczenia i diagnostyki.\",\n  \"pl_key_points\": [\n    \"Uruchomienie kampanii informacyjnych w szpitalach i przychodniach zachęcających kobiety do udziału w badaniach medycznych.\",\n    \"Przeznaczenie 20 milionów dolarów rocznie na edukację o badaniach klinicznych oraz zaburzeniach krzepnięcia krwi u kobiet.\",\n    \"Utworzenie stałego zespołu ekspertów do spraw przyspieszania prac nad lekami na choroby rzadkie.\",\n    \"Opracowanie publicznego planu działania dotyczącego chorób rzadkich, które najczęściej dotykają kobiety.\"\n  ],\n  \"eng_ai_title\": \"Gwenn’s Law: Increasing Women’s Participation in Medical Research and Rare Disease Awareness\",\n  \"eng_summary\": \"This bill aims to boost women's involvement in clinical trials and raise awareness about rare diseases and blood clotting disorders. Through new public campaigns and funding, women will have better access to information about cutting-edge medical research and treatments.\",\n  \"eng_key_points\": [\n    \"Launch of public awareness campaigns in hospitals and clinics to encourage women to join medical trials.\",\n    \"Allocation of $20 million annually for education on clinical trials and bleeding disorders in women.\",\n    \"Creation of a permanent Interagency Task Force to speed up the development of treatments for rare diseases.\",\n    \"Development of a public action plan focused on rare diseases that primarily affect women.\"\n  ],\n  \"de_ai_title\": \"Gwenn’s Law: Mehr Frauen in der medizinischen Forschung und Aufklärung über seltene Krankheiten\",\n  \"de_summary\": \"Dieses Gesetz zielt darauf ab, die Beteiligung von Frauen an klinischen Studien zu erhöhen und das Bewusstsein für seltene Krankheiten sowie Blutgerinnungsstörungen zu schärfen. Durch neue Informationskampagnen und Fördermittel erhalten Frauen besseren Zugang zu modernster medizinischer Forschung.\",\n  \"de_key_points\": [\n    \"Start von Aufklärungskampagnen in Krankenhäusern und Praxen, um Frauen zur Teilnahme an medizinischen Studien zu motivieren.\",\n    \"Bereitstellung von jährlich 20 Millionen Dollar für die Aufklärung über klinische Studien und Gerinnungsstörungen bei Frauen.\",\n    \"Gründung einer ständigen Expertengruppe zur Beschleunigung der Entwicklung von Medikamenten gegen seltene Krankheiten.\",\n    \"Erstellung eines öffentlichen Aktionsplans für seltene Krankheiten, die überproportional häufig Frauen betreffen.\"\n  ],\n  \"fr_ai_title\": \"Loi Gwenn : Accroître la participation des femmes à la recherche médicale et aux maladies rares\",\n  \"fr_summary\": \"Ce projet de loi vise à accroître la participation des femmes aux essais cliniques et à sensibiliser le public aux maladies rares et aux troubles de la coagulation. Grâce à de nouvelles campagnes d'information, les femmes auront un meilleur accès aux avancées médicales.\",\n  \"fr_key_points\": [\n    \"Lancement de campagnes de sensibilisation dans les hôpitaux pour encourager les femmes à participer aux essais médicaux.\",\n    \"Allocation de 20 millions de dollars par an pour l'éducation sur les essais cliniques et les troubles hémorragiques chez les femmes.\",\n    \"Création d'un groupe de travail permanent pour accélérer le développement de traitements contre les maladies rares.\",\n    \"Élaboration d'un plan d'action public axé sur les maladies rares qui touchent principalement les femmes.\"\n  ],\n  \"es_ai_title\": \"Ley Gwenn: Aumento de la participación de las mujeres en la investigación médica y enfermedades raras\",\n  \"es_summary\": \"Esta ley busca aumentar la participación de las mujeres en ensayos clínicos y mejorar la concienciación sobre enfermedades raras y trastornos de la coagulación. Mediante nuevas campañas y fondos, las mujeres tendrán mejor acceso a información sobre tratamientos innovadores.\",\n  \"es_key_points\": [\n    \"Lanzamiento de campañas de concienciación en hospitales y clínicas para animar a las mujeres a participar en estudios médicos.\",\n    \"Asignación de 20 millones de dólares anuales para educación sobre ensayos clínicos y trastornos de la coagulación en mujeres.\",\n    \"Creación de un grupo de trabajo permanente para acelerar el desarrollo de tratamientos para enfermedades raras.\",\n    \"Desarrollo de un plan de acción público sobre enfermedades raras que afectan desproporcionadamente a las mujeres.\"\n  ],\n  \"it_ai_title\": \"Legge Gwenn: Aumentare la partecipazione delle donne alla ricerca medica e alle malattie rare\",\n  \"it_summary\": \"Questa legge mira a potenziare il coinvolgimento delle donne negli studi clinici e a sensibilizzare l'opinione pubblica sulle malattie rare e i disturbi della coagulazione. Grazie a nuove campagne informative, le donne avranno un accesso facilitato alle scoperte mediche.\",\n  \"it_key_points\": [\n    \"Avvio di campagne di sensibilizzazione in ospedali e cliniche per incoraggiare le donne a partecipare ai test medici.\",\n    \"Stanziamento di 20 milioni di dollari all'anno per l'educazione sui test clinici e i disturbi emorragici femminili.\",\n    \"Istituzione di una task force permanente per accelerare lo sviluppo di cure per le malattie rare.\",\n    \"Creazione di un piano d'azione pubblico per le malattie rare che colpiscono prevalentemente le donne.\"\n  ],\n  \"nl_ai_title\": \"Gwenn’s Law: Verhoging van de deelname van vrouwen aan medisch onderzoek en zeldzame ziekten\",\n  \"nl_summary\": \"Dit wetsvoorstel is bedoeld om de betrokkenheid van vrouwen bij klinische proeven te vergroten en het bewustzijn over zeldzame ziekten en bloedstollingsstoornissen te verhogen. Door nieuwe campagnes krijgen vrouwen betere toegang tot informatie over medische innovaties.\",\n  \"nl_key_points\": [\n    \"Lancering van voorlichtingscampagnes in ziekenhuizen om vrouwen aan te moedigen deel te nemen aan medisch onderzoek.\",\n    \"Toewijzing van 20 miljoen dollar per jaar voor educatie over klinische proeven en stollingsstoornissen bij vrouwen.\",\n    \"Oprichting van een permanente werkgroep om de ontwikkeling van behandelingen voor zeldzame ziekten te versnellen.\",\n    \"Opstelling van een openbaar actieplan voor zeldzame ziekten die vrouwen onevenredig vaak treffen.\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Lançamento de campanhas de sensibilização em hospitais para incentivar as mulheres a participar em ensaios médicos.\",\n    \"Alocação de 20 milhões de dólares anuais para educação sobre ensaios clínicos e distúrbios hemorrágicos em mulheres.\",\n    \"Criação de uma força-tarefa permanente para acelerar o desenvolvimento de tratamentos para doenças raras.\",\n    \"Desenvolvimento de um plano de ação público focado em doenças raras que afetam desproporcionalmente as mulheres.\"\n  ],\n  \"category\": [\n    \"Health\"\n  ]\n}"
    },
    {
      "timestamp": "2026-04-17T11:24:31.554Z",
      "source_url": "https://www.congress.gov/119/bills/hr7694/BILLS-119hr7694ih.htm",
      "model": "gemini-flash-lite-latest",
      "prompt_sent": "\nROLE: Fact Checker.\nZADANIE: Porównaj SOURCE (oryginał) i SUMMARY (streszczenie przygotowane przez inne AI).\n\nTwoim celem jest wykrycie \"ZMYŚLONYCH KONKRETÓW\" (Fabricated Entities) w SUMMARY.\n\nSOURCE:\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7694 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7694 To direct the Secretary of Health and Human Services to carry out a public awareness campaign to increase participation by women in clinical trials that are conducted or supported by the National Institutes of Health, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES February 25, 2026 Mr. Gottheimer (for himself, Ms. Pettersen, and Mr. Lawler) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To direct the Secretary of Health and Human Services to carry out a public awareness campaign to increase participation by women in clinical trials that are conducted or supported by the National Institutes of Health, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Gwenn's Law''. SEC. 2. PUBLIC AWARENESS CAMPAIGN TO INCREASE PARTICIPATION OF WOMEN IN NIH CLINICAL TRIALS. (a) In General.--The Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (in this section referred to as the ``Secretary'') shall carry out a public awareness campaign to increase the participation of women in clinical trials conducted or supported by the National Institutes of Health. (b) Targeted Outreach.--In carrying out the campaign under subsection (a), the Secretary shall increase outreach at hospitals, physicians' offices, health centers, health care clinics, and other locations that the Secretary determines appropriate. (c) Priority.--In carrying out the campaign under subsection (a), the Secretary shall prioritize increasing the participation of women in clinical trials involving research on, and development of, products to prevent, diagnose, or treat rare diseases and conditions. (d) Authorization of Appropriations.--To carry out this section, there is authorized to be appropriated $10,000,000 for each of fiscal years 2027 through 2031. SEC. 3. PUBLIC AWARENESS CAMPAIGN TO INCREASE AWARENESS OF BLEEDING AND CLOTTING DISORDERS IN WOMEN. (a) In General.--The Secretary of Health and Human Services shall carry out a public awareness campaign to increase the number of women participating in programs of the Department of Health and Human Services for research, surveillance, and prevention with respect to bleeding and clotting disorders, including hemophilia. (b) Authorization of Appropriations.--To carry out this section, there is authorized to be appropriated $10,000,000 for each of fiscal years 2027 through 2031. SEC. 4. INTERAGENCY TASK FORCE ON ADVANCING TREATMENTS FOR RARE DISEASES. Part A of title III of the Public Health Service Act (42 U.S.C. 241 et seq.) is amended by adding at the end the following: ``SEC. 310C. INTERAGENCY TASK FORCE ON ADVANCING TREATMENTS FOR RARE DISEASES. ``(a) In General.--The Secretary shall maintain a permanent task force, to be known as the Interagency Task Force on Advancing Treatments for Rare Diseases (in this section referred to as the `Task Force'). The Secretary shall establish the Task Force not later than 90 days after the date of enactment of the legislation. ``(b) Composition.--The Task Force shall be composed of the following members: ``(1) The Secretary. ``(2) The Administrator of the Centers for Medicare & Medicaid Services. ``(3) The Commissioner of Food and Drugs. ``(4) The Director of the National Institutes of Health. ``(5) The Director of the Centers for Disease Control and Prevention. ``(6) Four individuals, to be appointed by the Secretary, who are-- ``(A) biopharmaceutical innovators with respect to rare diseases and conditions; ``(B) private health plan administrators; or ``(C) representatives of institutions or organizations conducting federally funded research with respect to rare diseases and conditions. ``(7) Four individuals, to be appointed by the Secretary, who are representatives of rare disease advocacy groups. ``(c) Duties.--The Task Force shall-- ``(1) assess-- ``(A) Federal agency activities concerning rare diseases, including projects involving two or more agencies; ``(B) overall programmatic funding; and ``(C) potential measurable outcomes to include in future reports; and ``(2) coordinate the efforts of the Department of Health and Human Services to incentivize research on, and development of, products for prevention, diagnosis, and treatment with respect to rare diseases and conditions, particularly rare diseases and conditions that disproportionately impact women.''. SEC. 5. ACTION PLAN FOR COORDINATING HHS EFFORTS WITH RESPECT TO CERTAIN RARE DISEASES AND CONDITIONS. (a) In General.--The Secretary of Health and Human Services shall prepare an action plan for coordinating efforts of the Department of Health and Human Services to incentivize research on, and development of, products for prevention, diagnosis, and treatment with respect to rare diseases and conditions that disproportionately impact women. (b) Submission and Public Availability.--Not later than 180 days after the date of enactment of this Act, the Secretary shall-- (1) complete the action plan required by subsection (a); (2) submit such action plan to the Congress; and (3) make such plan publicly available, including by posting on the websites of the Department of Health and Human Services and the National Institutes of Health. <all>\n\nSUMMARY TO EVALUATE:\nTitle: Gwenn’s Law: Increasing Women’s Participation in Medical Research and Rare Disease Trials\nSummary: This bill aims to boost women's involvement in clinical trials and raise awareness about bleeding disorders and rare diseases. It ensures that medical research better reflects women's health needs, leading to improved treatments and diagnosis.\nKey Points: Launch of public awareness campaigns in hospitals and clinics to encourage women to join clinical trials., Allocation of $20 million annually for education on rare diseases and blood clotting disorders in women., Establishment of a permanent interagency task force to speed up the development of treatments for rare diseases., Creation of a public action plan specifically for rare diseases that primarily affect women.\n\nZASADY OCENY:\n1. Sprawdź wszystkie LICZBY, DATY i KWOTY w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n2. Sprawdź wszystkie NAZWISKA, ORGANIZACJE i MIEJSCA w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n3. Sprawdź wszystkie konkretne DZIAŁANIA PRAWNE . Jeśli tego mechanizmu nie ma w SOURCE -> is_valid: false.\n\nWAŻNE: Abstrakcyjne pojęcia (np. \"transparentność\", \"zaufanie\") są dozwolone jako wnioski.\n\nOUTPUT (JSON):\n{\n  \"is_valid\": true/false,\n  \"issue\": \"fabricated_entity\" / \"contradiction\" / \"none\"\n}\n\nWYMAGANIA FORMATOWANIA:\n1. Odpowiedz WYŁĄCZNIE surowym obiektem JSON.\n2. NIE używaj bloków kodu Markdown.\n3. NIE dodawaj żadnych wstępów ani wyjaśnień przed ani po JSONie.\n4. JSON musi być poprawny i gotowy do parsowania.\n\n",
      "ai_response_raw": "{\n  \"is_valid\": false,\n  \"issue\": \"fabricated_entity\"\n}"
    },
    {
      "timestamp": "2026-04-17T11:13:54.808Z",
      "source_url": "https://www.congress.gov/119/bills/hr7694/BILLS-119hr7694ih.htm",
      "model": "gemini-flash-latest",
      "prompt_sent": "\nJesteś ekspertem od prawa Stanów Zjednoczonych, który ma za zadanie analizować dokumenty ustaw, uchwał oraz innych dokumentów legislacyjnych, a następnie przygotowywać z nich informacje w przystępny sposób dla obywateli. Twoim celem jest przedstawienie informacji tak, aby obywatele mogli sami ocenić wpływ legislacji na ich życie, nawet bez posiadania specjalistycznej wiedzy legislacyjnej. Skup się na faktach i obiektywnych skutkach wprowadzanych zmian, unikając wartościowania i osobistych opinii. Wszelki żargon prawny jest zabroniony. Prezentuj informacje w jasny, zwięzły i angażujący sposób, tak aby były zrozumiałe dla osoby bez wykształcenia prawniczego. Unikaj długich, złożonych zdań. Zamiast pisać \"projekt ma na celu nowelizację kodeksu podatkowego...\", napisz \"Zmiany w podatkach: nowe ulgi i obowiązki dla...\". Kontynuuj swoją pracę, dopóki nie rozwiążesz swojego zadania. Jeśli nie masz pewności co do generowanej treści, przeanalizuj dokument ponownie – nie zgaduj. Rozplanuj dobrze swoje zadanie przed przystąpieniem do niego. W podsumowaniu i kluczowych punktach, jeśli to możliwe i uzasadnione, podkreśl, jakie konkretne korzyści lub skutki (pozytywne lub negatywne) wprowadza ustawa dla życia codziennego obywateli, ich praw i obowiązków, finansów osobistych, bezpieczeństwa i innych ważnych kwestii (np. kategorycznych zakazów i nakazów czy najważniejszych konkretnych alokacji finansowych i terytorialnych).\n\nTwoja odpowiedź MUSI być w formacie JSON - i zawierać następujące klucze.\nZanim zwrócisz odpowiedź, dokładnie zweryfikuj, czy cała struktura JSON jest w 100% poprawna, włącznie ze wszystkimi przecinkami, nawiasami klamrowymi, kwadratowymi oraz cudzysłowami. Błędny JSON jest nieakceptowalny i uniemożliwi przetworzenie Twojej pracy.\n\nPrzeanalizuj dokładnie poniższy tekst dokumentu prawnego. To jest treść, na podstawie której masz wygenerować podsumowanie i kluczowe punkty:\n--- POCZĄTEK DOKUMENTU ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7694 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7694 To direct the Secretary of Health and Human Services to carry out a public awareness campaign to increase participation by women in clinical trials that are conducted or supported by the National Institutes of Health, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES February 25, 2026 Mr. Gottheimer (for himself, Ms. Pettersen, and Mr. Lawler) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To direct the Secretary of Health and Human Services to carry out a public awareness campaign to increase participation by women in clinical trials that are conducted or supported by the National Institutes of Health, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Gwenn's Law''. SEC. 2. PUBLIC AWARENESS CAMPAIGN TO INCREASE PARTICIPATION OF WOMEN IN NIH CLINICAL TRIALS. (a) In General.--The Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (in this section referred to as the ``Secretary'') shall carry out a public awareness campaign to increase the participation of women in clinical trials conducted or supported by the National Institutes of Health. (b) Targeted Outreach.--In carrying out the campaign under subsection (a), the Secretary shall increase outreach at hospitals, physicians' offices, health centers, health care clinics, and other locations that the Secretary determines appropriate. (c) Priority.--In carrying out the campaign under subsection (a), the Secretary shall prioritize increasing the participation of women in clinical trials involving research on, and development of, products to prevent, diagnose, or treat rare diseases and conditions. (d) Authorization of Appropriations.--To carry out this section, there is authorized to be appropriated $10,000,000 for each of fiscal years 2027 through 2031. SEC. 3. PUBLIC AWARENESS CAMPAIGN TO INCREASE AWARENESS OF BLEEDING AND CLOTTING DISORDERS IN WOMEN. (a) In General.--The Secretary of Health and Human Services shall carry out a public awareness campaign to increase the number of women participating in programs of the Department of Health and Human Services for research, surveillance, and prevention with respect to bleeding and clotting disorders, including hemophilia. (b) Authorization of Appropriations.--To carry out this section, there is authorized to be appropriated $10,000,000 for each of fiscal years 2027 through 2031. SEC. 4. INTERAGENCY TASK FORCE ON ADVANCING TREATMENTS FOR RARE DISEASES. Part A of title III of the Public Health Service Act (42 U.S.C. 241 et seq.) is amended by adding at the end the following: ``SEC. 310C. INTERAGENCY TASK FORCE ON ADVANCING TREATMENTS FOR RARE DISEASES. ``(a) In General.--The Secretary shall maintain a permanent task force, to be known as the Interagency Task Force on Advancing Treatments for Rare Diseases (in this section referred to as the `Task Force'). The Secretary shall establish the Task Force not later than 90 days after the date of enactment of the legislation. ``(b) Composition.--The Task Force shall be composed of the following members: ``(1) The Secretary. ``(2) The Administrator of the Centers for Medicare & Medicaid Services. ``(3) The Commissioner of Food and Drugs. ``(4) The Director of the National Institutes of Health. ``(5) The Director of the Centers for Disease Control and Prevention. ``(6) Four individuals, to be appointed by the Secretary, who are-- ``(A) biopharmaceutical innovators with respect to rare diseases and conditions; ``(B) private health plan administrators; or ``(C) representatives of institutions or organizations conducting federally funded research with respect to rare diseases and conditions. ``(7) Four individuals, to be appointed by the Secretary, who are representatives of rare disease advocacy groups. ``(c) Duties.--The Task Force shall-- ``(1) assess-- ``(A) Federal agency activities concerning rare diseases, including projects involving two or more agencies; ``(B) overall programmatic funding; and ``(C) potential measurable outcomes to include in future reports; and ``(2) coordinate the efforts of the Department of Health and Human Services to incentivize research on, and development of, products for prevention, diagnosis, and treatment with respect to rare diseases and conditions, particularly rare diseases and conditions that disproportionately impact women.''. SEC. 5. ACTION PLAN FOR COORDINATING HHS EFFORTS WITH RESPECT TO CERTAIN RARE DISEASES AND CONDITIONS. (a) In General.--The Secretary of Health and Human Services shall prepare an action plan for coordinating efforts of the Department of Health and Human Services to incentivize research on, and development of, products for prevention, diagnosis, and treatment with respect to rare diseases and conditions that disproportionately impact women. (b) Submission and Public Availability.--Not later than 180 days after the date of enactment of this Act, the Secretary shall-- (1) complete the action plan required by subsection (a); (2) submit such action plan to the Congress; and (3) make such plan publicly available, including by posting on the websites of the Department of Health and Human Services and the National Institutes of Health. <all>\n--- KONIEC DOKUMENTU ---\n\nPAMIĘTAJ: Twoja odpowiedź MUSI być wyłącznie poprawnym obiektem JSON. Nie dodawaj żadnych dodatkowych znaków, komentarzy ani tekstu przed znacznikiem '{' ani po znaczniku '}'. Cała odpowiedź musi być parsowalna jako JSON.\nNa podstawie POWYŻSZEGO dokumentu, wypełnij poniższą strukturę JSON:\nOto struktura JSON, której oczekuję (wypełnij ją treścią):\n{\n  \"pl_ai_title\": \"Nowy, krótki tytuł dla aktu prawnego po polsku, oddający sedno wprowadzanych zmian (np. maksymalnie 10-12 słów).\",\n  \"pl_summary\": \"2-3 zdania zwięzłego podsumowania treści aktu prawnego po polsku, napisane z perspektywy wpływu na życie codzienne obywateli.\",\n  \"pl_key_points\": [\n    \"Pierwszy krótki punkt po polsku dotyczący najważniejszych wprowadzanych rozwiązań lub zmian.\",\n    \"Drugi krótki punkt po polsku...\"\n  ],\n  \"eng_ai_title\": \"A new, short title for the legal act in English, capturing the essence of the changes (e.g., max 10-12 words).\",\n  \"eng_summary\": \"2-3 sentences summarizing the legal act in English, from the perspective of its impact on citizens' daily lives.\",\n  \"eng_key_points\": [\n    \"First short bullet point in English regarding the most important solutions or changes being introduced.\",\n    \"Second short bullet point in English...\"\n  ],\n  \"de_ai_title\": \"Ein neuer, kurzer Titel für das Rechtsdokument auf Deutsch, der den Kern der Änderungen erfasst (z.B. max. 10-12 Wörter).\",\n  \"de_summary\": \"2-3 Sätze Zusammenfassung des Rechtsdokuments auf Deutsch, aus der Perspektive seiner Auswirkungen auf das tägliche Leben der Bürger.\",\n  \"de_key_points\": [\n    \"Erster kurzer Stichpunkt auf Deutsch zu den wichtigsten eingeführten Lösungen oder Änderungen.\",\n    \"Zweiter kurzer Stichpunkt auf Deutsch...\"\n  ],\n  \"fr_ai_title\": \"Un nouveau titre court pour l'acte juridique en français, saisissant l'essence des changements (par exemple, 10-12 mots maximum).\",\n  \"fr_summary\": \"Résumé de 2-3 phrases de l'acte juridique en français, du point de vue de son impact sur la vie quotidienne des citoyens.\",\n  \"fr_key_points\": [\n    \"Premier court point en français concernant les solutions ou changements les plus importants introduits.\",\n    \"Deuxième court point en français...\"\n  ],\n  \"es_ai_title\": \"Un nuevo título breve para el acto jurídico en español, que recoja la esencia de los cambios (por ejemplo, máximo 10-12 palabras).\",\n  \"es_summary\": \"Resumen de 2-3 frases del acto jurídico en español, desde la perspectiva de su impacto en la vida cotidiana de los ciudadanos.\",\n  \"es_key_points\": [\n    \"Primer punto breve en español sobre las soluciones o cambios más importantes que se introducen.\",\n    \"Segundo punto breve en español...\"\n  ],\n  \"it_ai_title\": \"Un nuovo titolo breve per l'atto giuridico in italiano, che colga l'essenza delle modifiche (ad es. massimo 10-12 parole).\",\n  \"it_summary\": \"Riepilogo di 2-3 frasi dell'atto giuridico in italiano, dal punto di vista del suo impatto sulla vita quotidiana dei cittadini.\",\n  \"it_key_points\": [\n    \"Primo breve punto in italiano riguardante le soluzioni o le modifiche più importanti introdotte.\",\n    \"Secondo breve punto in italiano...\"\n  ],\n  \"nl_ai_title\": \"Een nieuwe, korte titel voor de rechtshandeling in het Nederlands, die de essentie van de wijzigingen weergeeft (bijv. max. 10-12 woorden).\",\n  \"nl_summary\": \"Samenvatting van 2-3 zinnen van de rechtshandeling in het Nederlands, vanuit het perspectief van de impact op het dagelijks leven van burgers.\",\n  \"nl_key_points\": [\n    \"Eerste korte punt in het Nederlands betreffende de belangrijkste geïntroduceerde oplossingen of wijzigingen.\",\n    \"Tweede korte punt in het Nederlands...\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Primeiro ponto curto em português sobre as soluções ou alterações mais importantes introduzidas.\",\n    \"Segundo ponto curto em português...\"\n  ],\n  \"category\": [\"Categorize the document into one category by default, based on the field it primarily concerns. Choose up to 3 if the document also touches upon SIGNIFICANT issues from other categories. You MUST select categories ONLY from the following list: Health, Education, Family, Taxes, Labor, Security, Environment, Courts and Law, Transport, Benefits, Real Estate, Media and Culture, Local Government, Migration, Agriculture, Public Investments, Informatization, Economy. If the document does not definitively fit any of these, you MUST use \"Other\". If you use \"Other\", it should be the ONLY category selected. Do NOT invent new categories. The response must be an array of strings, e.g., [\"Taxes\", \"Family\"].\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Ustawa Gwenn: Większy udział kobiet w badaniach medycznych i rzadkich chorobach\",\n  \"pl_summary\": \"Projekt ma na celu zwiększenie liczby kobiet biorących udział w badaniach klinicznych oraz podniesienie świadomości na temat chorób krwi i rzadkich schorzeń. Dzięki temu kobiety zyskają lepszy dostęp do nowoczesnych metod leczenia i diagnostyki dostosowanych do ich potrzeb.\",\n  \"pl_key_points\": [\n    \"Uruchomienie kampanii informacyjnych w szpitalach i przychodniach zachęcających kobiety do udziału w testach nowych leków.\",\n    \"Przeznaczenie 20 milionów dolarów rocznie na edukację o chorobach rzadkich oraz zaburzeniach krzepnięcia krwi u kobiet.\",\n    \"Powołanie stałego zespołu ekspertów, który zajmie się przyspieszeniem prac nad lekami na rzadkie choroby.\",\n    \"Stworzenie publicznego planu działania skupionego na chorobach, które najczęściej dotykają kobiety.\"\n  ],\n  \"eng_ai_title\": \"Gwenn’s Law: Increasing Women’s Participation in Medical Research and Rare Disease Trials\",\n  \"eng_summary\": \"This bill aims to boost women's involvement in clinical trials and raise awareness about bleeding disorders and rare diseases. It ensures that medical research better reflects women's health needs, leading to improved treatments and diagnosis.\",\n  \"eng_key_points\": [\n    \"Launch of public awareness campaigns in hospitals and clinics to encourage women to join clinical trials.\",\n    \"Allocation of $20 million annually for education on rare diseases and blood clotting disorders in women.\",\n    \"Establishment of a permanent interagency task force to speed up the development of treatments for rare diseases.\",\n    \"Creation of a public action plan specifically for rare diseases that primarily affect women.\"\n  ],\n  \"de_ai_title\": \"Gwenn's Gesetz: Mehr Frauen in der medizinischen Forschung und bei seltenen Krankheiten\",\n  \"de_summary\": \"Dieses Gesetz zielt darauf ab, die Beteiligung von Frauen an klinischen Studien zu erhöhen und das Bewusstsein für Blutgerinnungsstörungen und seltene Krankheiten zu schärfen. Dadurch sollen medizinische Behandlungen besser auf die Bedürfnisse von Frauen zugeschnitten werden.\",\n  \"de_key_points\": [\n    \"Start von Informationskampagnen in Krankenhäusern und Praxen, um Frauen zur Teilnahme an Medikamententests zu motivieren.\",\n    \"Bereitstellung von jährlich 20 Millionen Dollar für die Aufklärung über seltene Krankheiten und Blutgerinnungsstörungen bei Frauen.\",\n    \"Einrichtung einer ständigen Expertengruppe zur Beschleunigung der Entwicklung von Medikamenten für seltene Krankheiten.\",\n    \"Erstellung eines öffentlichen Aktionsplans für Krankheiten, die überproportional häufig Frauen betreffen.\"\n  ],\n  \"fr_ai_title\": \"Loi Gwenn : accroître la participation des femmes à la recherche médicale\",\n  \"fr_summary\": \"Ce projet de loi vise à augmenter la participation des femmes aux essais cliniques et à sensibiliser aux troubles de la coagulation et aux maladies rares. Il permet de s'assurer que les traitements médicaux sont mieux adaptés à la santé des femmes.\",\n  \"fr_key_points\": [\n    \"Lancement de campagnes de sensibilisation dans les hôpitaux pour encourager les femmes à participer aux tests de nouveaux médicaments.\",\n    \"Allocation de 20 millions de dollars par an pour l'éducation sur les maladies rares et les troubles sanguins chez les femmes.\",\n    \"Création d'un groupe de travail permanent pour accélérer le développement de traitements contre les maladies rares.\",\n    \"Élaboration d'un plan d'action public pour les maladies qui touchent principalement les femmes.\"\n  ],\n  \"es_ai_title\": \"Ley de Gwenn: Aumentar la participación de las mujeres en la investigación médica\",\n  \"es_summary\": \"Esta ley busca aumentar la participación de las mujeres en ensayos clínicos y mejorar la concienciación sobre trastornos hemorrágicos y enfermedades raras. El objetivo es que la medicina responda mejor a las necesidades específicas de las mujeres.\",\n  \"es_key_points\": [\n    \"Campañas de información en hospitales y clínicas para animar a las mujeres a participar en pruebas de nuevos fármacos.\",\n    \"Inversión de 20 millones de dólares anuales en educación sobre enfermedades raras y problemas de coagulación en mujeres.\",\n    \"Creación de un grupo de expertos permanente para acelerar el desarrollo de tratamientos para enfermedades poco comunes.\",\n    \"Desarrollo de un plan de acción público para enfermedades que afectan desproporcionadamente a las mujeres.\"\n  ],\n  \"it_ai_title\": \"Legge di Gwenn: aumentare la partecipazione delle donne alla ricerca medica\",\n  \"it_summary\": \"Questa legge mira a incrementare il coinvolgimento delle donne negli studi clinici e a sensibilizzare sui disturbi della coagulazione e sulle malattie rare. Assicura che la ricerca medica consideri maggiormente le esigenze di salute femminili.\",\n  \"it_key_points\": [\n    \"Avvio di campagne di sensibilizzazione negli ospedali per incoraggiare le donne a partecipare ai test sui farmaci.\",\n    \"Stanziamento di 20 milioni di dollari all'anno per l'educazione sulle malattie rare e i disturbi del sangue nelle donne.\",\n    \"Istituzione di una task force permanente per accelerare lo sviluppo di cure per le malattie rare.\",\n    \"Creazione di un piano d'azione pubblico per le malattie che colpiscono prevalentemente le donne.\"\n  ],\n  \"nl_ai_title\": \"Gwenn's Wet: Verhoging van de deelname van vrouwen aan medisch onderzoek\",\n  \"nl_summary\": \"Dit wetsvoorstel is bedoeld om de deelname van vrouwen aan klinische proeven te vergroten en de bewustwording over bloedstollingsziekten en zeldzame aandoeningen te verbeteren. Hierdoor sluiten medische behandelingen beter aan op de behoeften van vrouwen.\",\n  \"nl_key_points\": [\n    \"Invoering van informatiecampagnes in ziekenhuizen om vrouwen aan te moedigen deel te nemen aan medicijnonderzoek.\",\n    \"Toewijzing van 20 miljoen dollar per jaar voor voorlichting over zeldzame ziekten en bloedstollingsstoornissen bij vrouwen.\",\n    \"Oprichting van een permanente werkgroep om de ontwikkeling van behandelingen voor zeldzame ziekten te versnellen.\",\n    \"Opstelling van een openbaar actieplan voor ziekten die vrouwen onevenredig vaak treffen.\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Este projeto de lei visa aumentar a participação das mulheres em ensaios clínicos e sensibilizar para os distúrbios hemorrágicos e doenças raras. Garante que a investigação médica reflita melhor as necessidades de saúde das mulheres.\",\n  \"pt_key_points\": [\n    \"Lançamento de campanhas de sensibilização em hospitais para incentivar as mulheres a participar em testes de novos medicamentos.\",\n    \"Alocação de 20 milhões de dólares anuais para educação sobre doenças raras e distúrbios de coagulação em mulheres.\",\n    \"Criação de um grupo de trabalho permanente para acelerar o desenvolvimento de tratamentos para doenças raras.\",\n    \"Elaboração de um plano de ação público para doenças que afetam desproporcionalmente as mulheres.\"\n  ],\n  \"category\": [\n    \"Health\"\n  ]\n}"
    }
  ]
}